Stock Taper 
GOSS
$0.18
▼ DOWN 0.17% (-0.00)
KEY STATISTICS
Market Cap$85.69 M
52w High$3.87
52w Low$0.11
Dividend Yield—
Frequency—
P/E-0.25
Volume8.03M
Shares Out.488.85M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
Faheem Hasnain
COMPENSATION 2026
Salary$649,649
Stock Awards$0
Incentive Plan Pay$254,800
All Other Comp.$4,000
Total$2,300,455
ABOUT
SECTOR
Healthcare
WENT PUBLIC
February 8, 2019
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
162
PRICE TARGET
Target High$9.00
Target Low$0.30
Target Median$3.00
Target Consensus$3.47
UPCOMING EARNINGS
DateNov 4, 2026
DayWednesday
Rev. Est.$10.66M
NOV
4
WED
PRICE
$0.18 ▼ DOWN 0.17% (−$0.00)About Gossamer Bio, Inc.
https://www.gossamerbio.com ↗Gossamer Bio, Inc. is a San Diego-based clinical-stage biopharmaceutical company developing therapeutics in immunology, inflammation, and oncology, including inhaled and oral small molecules for pulmonary hypertension, IBD, CNS lymphoma, and multi...
INDUSTRY
Biotechnology
A PRODUCT GOSSAMER BIO, INC. IS KNOWN FOR
Seralutinib
Seralutinib, Gossamer Bio's lead Phase 3 inhaled drug, is being developed to treat pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.
Revenue by Products
| Icon | PRODUCT | Q2-2024 | Q3-2024 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|---|
 | License and Service | $88.75M | $0 ▼ | $0 | $0 |
ETFS HOLDING THIS STOCK
ETFS HOLDING
32
LISTED HERE
7
RANKED BY POSITION SIZE
INSTITUTIONAL OWNERSHIP
SHARES OWNED
24.89%
HOLDERS
264
TOP 12 OF 264 · RANKED BY POSITION SIZE
Nea Management Company, LLC
Blackrock, Inc.
Octagon Capital Advisors LP
Vanguard Group Inc
Aqr Capital Management LLC
State Street Corp
Arch Venture Management, LLC
Samsara Biocapital, LLC
Balyasny Asset Management L.P.
Palo Alto Investors LP
Acadian Asset Management LLC
Siren, L.L.C.
RATINGS SNAPSHOT
Overall rating: C+
Discounted Cash Flow4
Return On Equity5
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2
INSIDER TRADES
★
OFFICER: EVP, TECH OPS AND ADMIN
Christian Waage
Purchase · 2.9M shares
2026-08-24
★
OFFICER: CHIEF DEVELOPMENT OFFICER
Peterson Caryn
Purchase · 5.8M shares
2026-08-24
★
OFFICER: CHIEF COMMERCIAL OFFICER
Smith Robert Paul JR
Purchase · 5.8M shares
2026-08-24
★
OFFICER: COO/CFO
Giraudo Bryan
Purchase · 5.8M shares
2026-08-24
MOST RECENT ANALYST GRADES
GRADE SUMMARY
OUTPERFORM 2
BUY 2
NEUTRAL 2
OVERWEIGHT 1
UNDERWEIGHT 1
8 GRADES IN THE LAST 12 MONTHS
SECTORS PEERS
| PEER | PRICE | |
|---|---|---|
 CRVS | $14.39 | COMPARE |
 LXRX | $2.24 | COMPARE |
 OLMA | $10.75 | COMPARE |
 RIGL | $48.67 | COMPARE |
 FDMT | $14.97 | COMPARE |
 PRTA | $9.82 | COMPARE |
 RGNX | $8.94 | COMPARE |